| Literature DB >> 32616783 |
Luciana Carla Neves de Brito1, Janet Doolittle-Hall2, Chun-Teh Lee3, Kevin Moss2, Wilson Bambirra Júnior4, Warley Luciano Fonseca Tavares4, Antônio Paulino Ribeiro Sobrinho5, Flávia Rocha Fonseca Teles6.
Abstract
The aim of this study was to explore the microbial communities of endodontic infections at their apical portion by 16S rRNA Illumina sequencing and delineate the core microbiome of root canal infections and that of their associated clinical symptomatology. Samples were collected from fifteen subjects presenting one tooth with a root canal infection, and their associated symptoms were recorded. Samples were collected from the apical third of roots using a #10 K file and then amplified using multiple displacement amplification and PCR-amplified with universal primers. Amplicons were sequenced (V3-V4 hypervariable region of the 16S rRNA gene) using MiSeq (Illumina, CA). The microbial composition of the samples was determined using QIIME and HOMINGS. Data were analyzed using t tests and ANOVA. A total of 1,038,656 good quality sequences were obtained, and OTUs were assigned to 10 bacterial phyla, led by Bacteroidetes (51.2%) and Firmicutes (27.1%), and 94 genera were represented primarily by Prevotella (17.9%) and Bacteroidaceae G-1 (14.3%). Symptomatic teeth were associated with higher levels of Porphyromonas (p < 0.05) and Prevotella. P. endodontalis and P. oris were present in both cores. The present study demonstrated the complexity of the root canal microbiome and the "common denominators" of root canal infections and identified taxa whose virulence properties should be further explored. The polymicrobial etiology of endodontic infections has long been established. However, few studies have focused on expanding the breadth and depth of coverage of microbiome-infected root canals at their apical portion.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32616783 PMCID: PMC7331743 DOI: 10.1038/s41598-020-67828-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Bar charts of the composition of each of the samples examined and their average representation at the phylum (A), genus (B) and species levels (C). Species-level results were obtained using HOMINGS. The percentage of reads that were not identified by HOMINGS (i.e., unassigned reads) was not plotted.
Figure 2Principal coordinate analysis (PCoA) based on unweighted UniFrac distances obtained from the QIIME analytical pipeline for cavity status (a) and the presence of symptoms (b).
Figure 3Line plots of the microbial composition of the samples in which symptoms were present (blue) or absent (pink), at the phylum (A), genus (B) and species levels (C). Graphs show the mean relative abundance for phyla that were 0.01% different, genera that were 0.1% different, and species that were 0.2% different. Taxa were sorted according to relative abundance in the positive group. ***Taxa with statistically significant differences (p ≤ 0.05).
Figure 4Core microbiome of the samples analyzed according to the clinical symptomatology studied. The HOMINGS probes that were present with ≥ 0.1% relative abundance in ≥ 50% of all samples constitute the core microbiome (green). Samples were divided into two categories based on the absence (0) or presence (1) of symptoms. The core microbiome was subdivided into 2 groups based on the mean relative abundance of the taxa in samples in each clinical category (presence or absence of symptomatology). Furthermore, taxa that were present in ≥ 50% of samples in a single category but were not part of the core microbiome considering all samples constitute the core microbiomes. Taxa in the category core microbiomes were subgrouped based on the mean relative abundance of the taxa in samples in each clinical category. Taxa in bold were present in ≥ 75% of all samples (core) or samples in the indicated category (category cores).